Spineway USA inc

Spineway, established by Stéphane Le Roux in 2005, is an independent company which designs, develops and markets ranges of state-of-the-art surgical implants and ancillaries used at all levels in the spinal column (lumbar, thoracic and cervical). Spineway USA Inc is the principal subsidiary of Spineway SA, (Publicly traded French-based spinal manufacturer) dedicated to producing state-of-the-art medical devices and instrumentation to surgically treat various spinal pathologies. Spineway USA Inc., implants are FDA 510(k) cleared for use, completely Sterile packaged and complaint with new FDA regulations regarding UDI (Unique Device Identifier). Spineway USA strives to provide our technology to spine surgeons to improve the lives of the patient’s in their care. Spineway's offer has historically been centered on the provision of gold-standard products meeting the clearly identified needs of international markets. The Spineway ranges allow over 80% of operating needs to be met. Rolled out via a network of 48 specialist distributors, Spineway products are available in more than 40 countries. The company was listed on the stock market for the first time on 13 February 2013 at the NYSE Alternext Paris under the symbol ALSPW. For more information please contact us at (jrl@spinewayusa.com)